These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

371 related items for PubMed ID: 29721143

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Diagnosis and classification of Vogt-Koyanagi-Harada disease.
    Sakata VM, da Silva FT, Hirata CE, de Carvalho JF, Yamamoto JH.
    Autoimmun Rev; 2014; 13(4-5):550-5. PubMed ID: 24440284
    [Abstract] [Full Text] [Related]

  • 8. [Vogt-Koyanagi-Harada disease complicated by subretinal neovessels].
    Lepvrier-Guibal N, Korobelnik JF, Xuan TH.
    J Fr Ophtalmol; 1995; 18(4):305-11. PubMed ID: 7769166
    [Abstract] [Full Text] [Related]

  • 9. Bilateral retinal detachment in a patient with Vogt-Koyanagi-Harada syndrome.
    McGehee BE, Chaljub G, Shah RK, Oto A, Camacho AC, Tang RA.
    Emerg Radiol; 2005 Nov; 11(6):366-71. PubMed ID: 16237574
    [Abstract] [Full Text] [Related]

  • 10. Optical coherence tomography in the acute and chronic phases of Vogt-Koyanagi-Harada disease.
    Parc C, Guenoun JM, Dhote R, Brézin A.
    Ocul Immunol Inflamm; 2005 Nov; 13(2-3):225-7. PubMed ID: 16019683
    [Abstract] [Full Text] [Related]

  • 11. [Vogt-Koyanagi-Harada disease].
    Kjeka O, Krohn J.
    Tidsskr Nor Laegeforen; 2005 Aug 25; 125(16):2195-7. PubMed ID: 16138134
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Vogt-Koyanagi-Harada syndrome Case report.
    Nicula C, Szabo I.
    Rom J Ophthalmol; 2016 Aug 25; 60(3):181-183. PubMed ID: 29450345
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Vogt-Koyanagi-Harada syndrome associated with cutaneous malignant melanoma: an 11-year follow-up.
    Aisenbrey S, Lüke C, Ayertey HD, Grisanti S, Perniok A, Brunner R.
    Graefes Arch Clin Exp Ophthalmol; 2003 Dec 25; 241(12):996-9. PubMed ID: 14618342
    [Abstract] [Full Text] [Related]

  • 17. Bilateral Iris Depigmentation and Ocular Hypotony as End-Stage Manifestations of Untreated Vogt-Koyanagi-Harada Disease.
    Cuevas M, de-la-Torre A, Córdoba A.
    Ocul Immunol Inflamm; 2018 Dec 25; 26(7):1101-1106. PubMed ID: 28548582
    [Abstract] [Full Text] [Related]

  • 18. Presumed Vogt-Koyanagi-Harada disease with unilateral ocular involvement: report of three cases.
    Usui Y, Goto H, Sakai J, Takeuchi M, Usui M, Rao NA.
    Graefes Arch Clin Exp Ophthalmol; 2009 Aug 25; 247(8):1127-32. PubMed ID: 19308440
    [Abstract] [Full Text] [Related]

  • 19. Vogt-Koyanagi-Harada disease.
    Damico FM, Kiss S, Young LH.
    Semin Ophthalmol; 2005 Aug 25; 20(3):183-90. PubMed ID: 16282153
    [Abstract] [Full Text] [Related]

  • 20. [Intravenous immunoglobulin therapy in Vogt-Koyanagi-Harada syndrome].
    González-Delgado M, González C, Blázquez JI, Salas-Puig J, Castro J, Hernández-Lahoz C.
    Neurologia; 2004 Sep 25; 19(7):401-3. PubMed ID: 15273890
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.